BOLERO-1 reports HER2-positive breast cancer latest PFS data
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype
Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
Examining cell-free DNA provides non-invasive detection of malignancies in Hodgkin lymphoma
Best of ASH 2014
ASH 2014: Highlights in CLL from ASH 2014
Oprozomib shows potential in the treatment of multiple myeloma
Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma
Combination therapy for high-risk MDS? Not quite yet
Results of HD2000 trial comparing combination therapies in advanced-stage Hodgkin's lymphoma
ASH 2014: Highlights in mantle cell lymphoma
ASH 2014: Highlights in multiple myeloma